No Detail Found!

Comparison of Efficacy of Oral Progesterone and Micronized Progesterone Pessary in Reduction of Incidence of Spontaneous Preterm Births.

Author(s)
Nighat Afridi Gynaecology and obstetrics Department, Combined Military Hospital Nowshera Cantt, Pakistan
Umair Masood Gynaecology and obstetrics Department, Combined Military Hospital Nowshera Cantt, Pakistan
Salahuddin Balooch Gynaecology and obstetrics Department, Combined Military Hospital Nowshera Cantt, Pakistan
Saifullah Khan The Agha Khan University Karachi, Pakistan
Shahgul Khan Khyber Medical College Peshawar-Pakistan
Abstract
Background: Preterm births are among the leading causes of fetomaternal mortality and morbidity. Progesterone is routinely used for the treatment of preterm births but scarce data is available that compared the efficacy of oral progesterone (dydrogesterone) with micronized progesterone (cyclogest pessary/rectal) to reduce the incidence of spontaneous preterm births in our local population. Methods: This randomized controlled trial was conducted at Gynaecology and Obstetrics department of Combined Military Hospital Nowshera from June to November 2018. Patients were divided into two groups. Group A was given oral progesterone (10 mg twice daily) while group B was given cyclogest pessary (400 mg daily) per rectal use. Efficacy of both groups was compared applying chi-square test and p-value =0.05 was considered significant. Results: Total 152 patients were included in study with 1:1 randomization (76 patients in each group). Mean gestational age was 29.6 weeks±1.5SD. Micronized progesterone cyclogest pessary per rectal usage is associated with reduction in preterm C-section, maternal systemic side effects., tocolysis use, NICU admissions, perinatal mortality, intraventricular haemorrhage, oxygen use at 28th day of life and retinopathy of prematurity (p0.05). Conclusion: Prophylactic micronized progesterone per-rectal use is more effective in reducing preterm birth in patients at high risk of prematurity as compare to oral progesterone (dydrogesterone). Cyclogest pessary 400mg per rectal usage is associated with less maternal and neonatal complications.
Publication Details
Page(s) 248-251
DOI DOI not available
Published Journal: Journal of Ayub Medical College, Volume: 31, Issue: 2, Year: 2019

Request the full text from PASTIC

Keywords
Cyclogest pessary (micronized progesterone), Dydrogesterone, Preterm birth
0

Citations

0

Downloads

45

Views